Sandra Vatter

573 total citations
11 papers, 477 citations indexed

About

Sandra Vatter is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Sandra Vatter has authored 11 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Organic Chemistry, 7 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Sandra Vatter's work include Quinazolinone synthesis and applications (5 papers), Phosphodiesterase function and regulation (3 papers) and Synthesis and Biological Evaluation (3 papers). Sandra Vatter is often cited by papers focused on Quinazolinone synthesis and applications (5 papers), Phosphodiesterase function and regulation (3 papers) and Synthesis and Biological Evaluation (3 papers). Sandra Vatter collaborates with scholars based in Germany, United States and Switzerland. Sandra Vatter's co-authors include Gerhard Eisenbrand, Karl‐Heinz Merz, Richard Jove, Sangkil Nam, James Turkson, Donghwa Kim, Ralf Buettner, Jin Cheng, Xinlai Cheng and Gudrun Pahlke and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Medicinal Chemistry and Journal of Neurochemistry.

In The Last Decade

Sandra Vatter

10 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Vatter Germany 9 240 204 126 54 47 11 477
Stanley W. Marynowski United States 7 412 1.7× 93 0.5× 48 0.4× 26 0.5× 66 1.4× 8 633
M. Juliana United States 7 202 0.8× 59 0.3× 77 0.6× 35 0.6× 31 0.7× 9 395
Anthony J. Galati United States 12 454 1.9× 81 0.4× 89 0.7× 59 1.1× 41 0.9× 16 765
Julie A. Arlotti United States 15 458 1.9× 86 0.4× 89 0.7× 23 0.4× 63 1.3× 19 775
Hidetomo Kikuchi Japan 12 372 1.6× 65 0.3× 117 0.9× 55 1.0× 28 0.6× 22 552
Todd Schuster United States 8 327 1.4× 38 0.2× 57 0.5× 66 1.2× 94 2.0× 13 624
Amanda K. Smolarek United States 11 255 1.1× 111 0.5× 156 1.2× 175 3.2× 127 2.7× 12 646
Ichen Chen United States 6 187 0.8× 67 0.3× 37 0.3× 31 0.6× 49 1.0× 6 451
Guifen Xu United States 14 184 0.8× 72 0.4× 38 0.3× 33 0.6× 20 0.4× 25 454
Indra Dwivedy India 5 431 1.8× 109 0.5× 147 1.2× 19 0.4× 71 1.5× 14 790

Countries citing papers authored by Sandra Vatter

Since Specialization
Citations

This map shows the geographic impact of Sandra Vatter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Vatter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Vatter more than expected).

Fields of papers citing papers by Sandra Vatter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Vatter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Vatter. The network helps show where Sandra Vatter may publish in the future.

Co-authorship network of co-authors of Sandra Vatter

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Vatter. A scholar is included among the top collaborators of Sandra Vatter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Vatter. Sandra Vatter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
2.
Cheng, Xinlai, et al.. (2013). 7,7′-Diazaindirubin—A small molecule inhibitor of casein kinase 2 in vitro and in cells. Bioorganic & Medicinal Chemistry. 22(1). 247–255. 35 indexed citations
3.
Cheng, Xinlai, et al.. (2010). Synthesis and cytotoxicity of novel indirubin-5-carboxamides. Bioorganic & Medicinal Chemistry. 18(12). 4509–4515. 38 indexed citations
4.
Nam, Seok Jin, Ralf Buettner, James Turkson, et al.. (2008). Indirubin derivatives inhibit SFKs/Stat signaling associated with apoptosis in human cancer cells. Planta Medica. 74(9). 1 indexed citations
5.
6.
Fritz, Jessica, Melanie Kern, Gudrun Pahlke, Sandra Vatter, & Doris Marko. (2006). Biological activities of malvidin, a red wine anthocyanidin. Molecular Nutrition & Food Research. 50(4-5). 390–395. 13 indexed citations
7.
Vatter, Sandra, Karl‐Heinz Merz, & G. Eisenbrand. (2005). Searching for cellular targets of novel pteridines downstream of cAMP PDE inhibition. International Journal of Clinical Pharmacology and Therapeutics. 43(12). 607–608.
8.
Merz, Karl‐Heinz, et al.. (2005). Molecular targets of indirubins. International Journal of Clinical Pharmacology and Therapeutics. 43(12). 592–594. 8 indexed citations
9.
Vatter, Sandra, Gudrun Pahlke, Joachim W. Deitmer, & Gerhard Eisenbrand. (2005). Differential phosphodiesterase expression and cytosolic Ca2+ in human CNS tumour cells and in non‐malignant and malignant cells of rat origin. Journal of Neurochemistry. 93(2). 321–329. 8 indexed citations
10.
Nam, Sangkil, Ralf Buettner, James Turkson, et al.. (2005). Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells. Proceedings of the National Academy of Sciences. 102(17). 5998–6003. 242 indexed citations
11.
Vetter, Walter, Mark E. Hahn, Gregg T. Tomy, et al.. (2004). Biological Activity and Physicochemical Parameters of Marine Halogenated Natural Products 2,3,3′,4,4′,5,5′-Heptachloro-1′-Methyl-1,2′-Bipyrrole and2,4,6-Tribromoanisole. Archives of Environmental Contamination and Toxicology. 48(1). 1–9. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stanley W. Marynowski Breakdown of academic impact, for papers by M. Juliana Breakdown of academic impact, for papers by Anthony J. Galati Breakdown of academic impact, for papers by Julie A. Arlotti Breakdown of academic impact, for papers by Hidetomo Kikuchi Breakdown of academic impact, for papers by Todd Schuster Breakdown of academic impact, for papers by Amanda K. Smolarek Breakdown of academic impact, for papers by Ichen Chen Breakdown of academic impact, for papers by Guifen Xu Breakdown of academic impact, for papers by Indra Dwivedy
Rankless by CCL
2026